|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-8-10
|
|
pubmed:abstractText |
Inhaled glucocorticoids may decrease exacerbations in some patients with COPD, and oral glucocorticoids may improve FEV(1) and shorten hospital stay during exacerbations. The mechanism of these improvements is unknown. This study examines the effect of oral glucocorticoids on markers of neutrophilic airway inflammation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
126
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
389-93
|
|
pubmed:dateRevised |
2005-2-3
|
|
pubmed:meshHeading |
pubmed-meshheading:15302722-Administration, Oral,
pubmed-meshheading:15302722-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15302722-Female,
pubmed-meshheading:15302722-Glucocorticoids,
pubmed-meshheading:15302722-Humans,
pubmed-meshheading:15302722-Interleukin-8,
pubmed-meshheading:15302722-Male,
pubmed-meshheading:15302722-Neutrophil Activation,
pubmed-meshheading:15302722-Peroxidase,
pubmed-meshheading:15302722-Prednisone,
pubmed-meshheading:15302722-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:15302722-Sputum
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids.
|
|
pubmed:affiliation |
Department of Pneumology, Silesian Medical Academy, Katowice, ul. Medykow 14, Poland. adagne@mp.pl
|
|
pubmed:publicationType |
Journal Article
|
